Cited by 173Berberine and alkaloids researchNatural Antidiabetic Agents StudiesMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

Derosa, Giuseppe, Maffioli, Pamela, Cicero, Arrigo FG·2012·Expert Opinion on Biological Therapy

DOI 10.1517/14712598.2012.704014

Open this paper in CoChat — free account

Abstract

INTRODUCTION: Type 2 diabetes mellitus and hypercholesterolemia have proven to give an increased incidence of cardiovascular diseases (CVD). Recent studies have suggested that the natural alkaloid berberine could have pharmacological activities potentially useful in diabetes and hypercholesterolemia management. AREAS COVERED: The aim of this review is to evaluate the metabolic properties of the natural alkaloid berberine, and its potential application to the treatment of diabetes and CVD prevention. EXPERT OPINION: Berberine proved to be effective in improving glycemic control and lipid profile. The modern investigation on berberine pharmacological activity is actually developing and numerous scientific evidences are actually in progress and reported in international congresses. The near future perspective is the isolation or neo-synthesis of berberine analogs with a higher bioavailability. The anti-hyperlipidemic and anti-diabetic effects of berberine have to be related to markers of improvement in organ damage in humans; longer trials are needed to better evaluate the safety profile of the molecule, when administered alone or in association with other anti-hyperlipidemic or anti-diabetic drugs, especially in the European population.

Integrity signals

Registry

Crossref · 10.1517/14712598.2012.704014

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
Lan, T., Shen, X., Liu, P., Liu, W., Xu, S., Xie, X. S., Jiang, Q. L., Li, W., & Huang, H. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.012 · Cited by 80
Retracted
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., Fernandes, J. D. D. R., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D. A., Shaw, J. E., & Makaroff, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 7,121
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. E. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 4,018
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
Turner, R. C. (1999) · JAMA · doi:10.1001/jama.281.21.2005 · Cited by 2,375
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Arzneimittelforschung
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 636
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573 · cited 1×
“Another confirmation that berberine is effective and safe in the treatment of type 2 diabetes and dyslipidemia came from a study [71] where 116 patients with type 2 diabetes and dyslipidemia were randomly allocated to receive berberine (1.”
Background
Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I
Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z., Wang, S., Zhou, Z.-X., Song, D., Wang, Y., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 442
Berberine improves glucose metabolism through induction of glycolysis
Yin, J., Gao, Z., Liu, D., Liu, Z., & Ye, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2007 · Cited by 418
Anti-cancer natural products isolated from chinese medicinal herbs
Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., et al. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-27 · Cited by 398
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
Yin, J., Zhang, H., & Ye, J. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008784534330 · Cited by 377
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Li, H., Dong, B., Park, S. W., Lee, H.-S., Chen, W., & Liu, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052407 · Cited by 352
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
Brusq, J.-M. G., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 344
An update on regional variation in cardiovascular mortality within Europe
Müller‐Nordhorn, J., Binting, S., Roll, S., & Willich, S. N. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm604 · Cited by 296
Cardiovascular actions of berberine
Lau, C., Yao, X., Chen, Z., Ko, W., & Huang, Y. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00068.x · Cited by 281
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., & Qin, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.095 · Cited by 277
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
Kong, W., Zhang, H., Song, D., Xue, R., Zhao, W., Wei, J., Wang, Y., Shan, N., Zhou, Z., Yang, P., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.013 · Cited by 267
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., & Weng, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016556 · Cited by 262
Berberine: Therapeutic Potential of an Alkaloid Found in Several Medicinal Plants
Birdsall, T. C., & Kelly, G. S. (1997) · Alternative medicine review · Cited by 258
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Cheng, Z., Pang, T., Gu, M., Gao, A., Xie, C., Li, J.-Y., Nan, F., & Li, J. X. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.007 · Cited by 241
Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.
Leng, S.-H., Lu, F., & Xu, L. (2004) · PubMed · Cited by 237
Effects of berberine on glucose metabolism in vitro
Yin, J., Hu, R., Chen, M., Tang, J., Li, F., Yang, Y., & Chen, J. (2002) · Metabolism · doi:10.1053/meta.2002.34715 · Cited by 234
Berberine decreases PCSK9 expression in HepG2 cells
Cameron, J., Ranheim, T., Kulseth, M. A., Leren, T. P., & Berge, K. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.004 · Cited by 232
Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats
Zhou, J., Zhou, S., Tang, J., Zhang, K., Guang, L.-X., Huang, Y., Xu, Y. X., Ying, Y., Zhang, L., & Li, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.056 · Cited by 208
Berberine Modifies Cysteine 179 of IκBα Kinase, Suppresses Nuclear Factor-κB–Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis
Pandey, M. K., Sung, B., Kunnumakkara, A. B., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0511 · Cited by 201
Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Zeng, X., Zeng, X., & Li, Y.-Y. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00533-2 · Cited by 192
Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics
Gu, Y., Zhang, Y., Shi, X., Li, X., Hong, J., Chen, J., Gu, W., Lu, X., Xu, G., & Ning, G. (2010) · Talanta · doi:10.1016/j.talanta.2010.01.015 · Cited by 190
Berberine stimulates glucose transport through a mechanism distinct from insulin
Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.025 · Cited by 187
Insulin Sensitizing and Insulinotropic Action of Berberine from Cortidis Rhizoma
Ko, B., Choi, S. B., Park, S. K., Jang, J. S., Kim, Y. E., & Park, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1431 · Cited by 184
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Xie, W., Gu, D., Li, J., Cui, K., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024520 · Cited by 183
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
Choi, B.-H., Ahn, I., Kim, Y., Park, J.-W., Lee, S. Y., Hyun, C., & Do, M. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.71 · Cited by 166
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Kong, W., Wei, J., Zuo, Z.-Y., Wang, Y., Song, D., You, X., Zhao, L., Pan, H.-N., & Jiang, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.037 · Cited by 162
HEPATOBILIARY EXCRETION OF BERBERINE
Tsai, P.-L., & Tsai, T. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.405 · Cited by 160
Chronic Effects of Berberine on Blood, Liver Glucolipid Metabolism and Liver PPARs Expression in Diabetic Hyperlipidemic Rats
Zhou, J. Y., Zhou, S. W., Zhang, K. B., Tang, J., Guang, L. X., Ying, Y., Xu, Y. X., Zhang, L., & Li, D. D. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1169 · Cited by 156
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
Abidi, P., Zhou, Y., Jiang, J.-D., & Liu, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 152
Modulating gut microbiota as an anti-diabetic mechanism of berberine
Han, J.-L., Lin, H., & Huang, W. (2011) · Medical Science Monitor · doi:10.12659/msm.881842 · Cited by 142
Inhibitory effect of berberine on tert -butyl hydroperoxide-induced oxidative damage in rat liver
Hwang, J.-M., Wang, C., Chou, F.-P., Tseng, T., Hsieh, Y., Lin, W., & Chu, C.-Y. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0351-9 · Cited by 140
Berberine Activates GLUT1-Mediated Glucose Uptake in 3T3-L1 Adipocytes
Kim, S. H., Shin, E.-J., Kim, E.-D., Bayaraa, T., Frost, S. C., & Hyun, C. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2120 · Cited by 136
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
Affuso, F., Ruvolo, A., Micillo, F., Saccà, L., & Fazio, S. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.05.017 · Cited by 135
Cardiovascular effects of berberine in patients with severe congestive heart failure
Marin ‐ NETO, J. A., Maciel, B. C., Secches, A. L., & Gallo, L. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110411 · Cited by 128
Vasorelaxant and antiproliferative effects of berberine
Ko, W. H., Yao, X., Lau, C., Law, W.-I., Chen, Z., Kwok, W., Ho, W. K. K., & Huang, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00339-3 · Cited by 121
Eulipidemic Effects of Berberine Administered Alone or in Combination with Other Natural Cholesterol-lowering Agents
Cicero, A. F. G., Rovati, L. C., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296582 · Cited by 114
Self-citation
Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes
Suksomboon, N., Poolsup, N., Boonkaew, S., & Suthisisang, C. C. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.07.059 · Cited by 112
Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats
Lu, S.-S., Yu, Y.-L., Zhu, H., Liu, X., Liu, L., Liu, Y.-W., Wang, P., Xie, L. Y., & Wang, G.-J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0419 · Cited by 111
The antihypertensive and vasodilator effects of aqueous extract fromBerberis vulgaris fruit on hypertensive rats
Fatehi‐Hassanabad, Z., Jafarzadeh, M., Tarhini, A., & Fatehi, M. (2005) · Phytotherapy Research · doi:10.1002/ptr.1661 · Cited by 110
Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans
Cheng, F., Wang, Y., Li, J., Su, C., Wu, F., Xia, W., Yang, Z., Yu, B., Qiu, Y., & Tao, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.090 · Cited by 108
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus
Zhang, W., Yan-cheng, X. U., Fang-jian, G. U. O., Ye, M., & Li, M. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811010-00003 · Cited by 107
Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase
Liu, W., Hei, Z., Nie, H., Tang, F., Huang, H., Li, X., Yan-hui, D. E. N. G., Chen, S., Guo, F., Huang, W., et al. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200804020-00009 · Cited by 106
Berberine-induced LDLR up-regulation involves JNK pathway
Lee, S., Lim, H., Park, J., Lee, K., Jang, Y., & Park, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.060 · Cited by 94
Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells
Liang, K., Yin, S., Ting, C.-T., Lin, S., Hsueh, C., Chen, C.-Y., & Hsu, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.034 · Cited by 89
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
Xing, L., Zhang, L. R., Liu, T., Hua, Y., Zheng, P., & Ji, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.036 · Cited by 89
Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements
Li, H., Chen, W., Zhou, Y., Abidi, P., Sharpe, O., Robinson, W. H., Kraemer, F. B., & Liu, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800375-jlr200 · Cited by 85
Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice
Guo, Y., Pope, C., Cheng, X., Zhou, H., & Klaassen, C. D. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.058 · Cited by 77
Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice1
Pan, L., Tang, Q., Fu, Q., Hu, B., Xiang, J., & Qian, J.-Q. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00186.x · Cited by 76
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome
Affuso, F. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i3.77 · Cited by 75
Mechanism of vasodilatory effect of berberine in rat mesenteric artery
Chiou, W., Yen, M., & Chieh-Fu, C. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90832-b · Cited by 74
Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
Kang, D. G., Sohn, E. J., Kwon, E. K., Han, J. H., Oh, H., & Lee, H. S. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00005-3 · Cited by 74
Berberine Acutely Inhibits Insulin Secretion from β-Cells through 3′,5′-Cyclic Adenosine 5′-Monophosphate Signaling Pathway
Zhou, L., Wang, X., Shao, L., Yang, Y., Shang, W., Yuan, G., Jiang, B., Li, F., Tang, J., Hua, J., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1752 · Cited by 73
Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury
Liang, K., Ting, C.-T., Yin, S., Chen, Y., Lin, S., Liao, J. K., & Hsu, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.028 · Cited by 73
Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
Liu, L., Yu, Y., Yang, J., Yang, L., Liu, Y., Liang, Y., Liu, X., Xie, L. Y., & Wang, G. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0502-0 · Cited by 68
Berberine Inhibits the Production of Lysophosphatidylcholine-induced Reactive Oxygen Species and the ERK1/2 Pathway in Vascular Smooth Muscle Cells
Cho, B. J., Im, E. K., Kwon, J. H., Lee, K.-H., Shin, H.-J., Oh, J., Kang, S., Chung, J. H., & Jang, Y. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13249-3 · Cited by 65
Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
Wang, Z., Lu, F., Leng, S.-H., Fang, X., Chen, G., Wang, Z.-S., Dong, L., & Yan, Z.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6004 · Cited by 61
A biochemical study on the hypotensive effect of berberine in rats
Chun, Y. T., Yip, T. T., Lau, K. L., Kong, Y. C., & Sankawa, U. (1979) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(79)90085-5 · Cited by 59
Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
Yi, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.876 · Cited by 57
Effect of Berberine on Regression of Pressure-Overload Induced Cardiac Hypertrophy in Rats
Hong, Y., Hui, S.-C., Chan, T. W., & Hou, J.-Y. (2002) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x02000612 · Cited by 57
Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells
Huang, C. G., Chu, Z. L., Wei, S., Jiang, H., & Jiao, B. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00133-0 · Cited by 55
Berberine-induced activation of 5′-adenosine monophosphate–activated protein kinase and glucose transport in rat skeletal muscles
Ma, X., Egawa, T., Kimura, H., Karaike, K., Masuda, S., Iwanaka, N., & Hayashi, T. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.009 · Cited by 54
Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition
Liu, W., Tang, F., Deng, Y., Li, X., Lan, T., Zhang, X., Huang, H., & Liu, P. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0024-y · Cited by 53
Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis
Zhao, W., Xue, R., Zhou, Z., Kong, W., & Jiang, J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.007 · Cited by 53
Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway
Xie, X., Li, W., Lan, T., Liu, W., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., & Huang, H. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-024 · Cited by 52
Targeting metabolic syndrome: Candidate natural agents
Xia, X., & Weng, J. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00090.x · Cited by 51
Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy
Hong, Y., Hui, S. S. C., Chan, B. T.-Y., & Hou, J.-Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00144-9 · Cited by 50
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
Holy, E. W., Akhmedov, A., Lüscher, T. F., & Tanner, F. C. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.011 · Cited by 48
Berberine-induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
Wang, J.-M., Yang, Z., Xu, M.-G., Chen, L., Wang, Y., Su, C., & Tao, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.037 · Cited by 45
Berberine-Induced Upregulation of Circulating Endothelial Progenitor Cells Is Related to Nitric Oxide Production in Healthy Subjects
Xu, M.-G., Wang, J., Chen, L., Wang, Y., Yang, Z., & Tao, J. (2008) · Cardiology · doi:10.1159/000157336 · Cited by 43
Berberine-induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity
Xu, M.-G., Wang, J.-M., Chen, L., Wang, Y., Yang, Z., & Tao, J. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002311 · Cited by 38
[Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes].
Wang, S.-H., Wang, W., Wang, X., & Chen, W. (2004) · PubMed · Cited by 35
Inhibitory effects of berberine on ATP-sensitive K+ channels in cardiac myocytes
Wang, Y.-X., Zheng, Y., & Zhou, X.-B. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00663-2 · Cited by 33
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Cicero, A. F. G. (2009) · Nutrition and Dietary Supplements · doi:10.2147/nds.s6084 · Cited by 31
Self-citation
Mechanism of the Aortic Relaxation Induced by Low Concentrations of Berberine
Wong, K. (1998) · Planta Medica · doi:10.1055/s-2006-957575 · Cited by 26
Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs.
Ölmez, E., & Ilhan, M. (1992) · PubMed · Cited by 24
Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs.
Huang, W., Yan, H., Jin, J., Yu, C., & Zhang, H. (1992) · PubMed · Cited by 23
Biochemical pathways in the antiatherosclerotic effect of berberine
Guo, Y., Wang, Q., Fang-ming, L. I., Jiang, X. M., Zuo, Y., & Wang, L. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200807010-00009 · Cited by 20
Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription?
Cicero, A. F. G., & Ertek, S. (2008) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-008-0011-6 · Cited by 19
Self-citation
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational
Sénécal, M., Fodor, G. J., Gagné, C., Genest, J. J., Lavoie, M.-A., McPherson, R., Marentette, M. A., & Sebaldt, R. J. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802575734 · Cited by 9
Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription?
Cicero, A. F. G., & Ertek, S. (2008) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/s12349-008-0011-6 · Cited by 3
Self-citation
LONG-TERM EFFECTS OF A BERBERINE BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC PATIENTS
Cicero, A. F. G., Derosa, G., Maffioli, P., Gerocarni, B., Grandi, E., & Borghi, C. (2011) · Journal of Hypertension · doi:10.1097/00004872-201106001-00404 · Cited by 2
Self-citation

Flagged first, then by citations

Research works printed but not linked: 12

Birdsall TC, 1997, Altern Med Rev, 2, 94
Lu SS, 2009, J Endocrinol, 200, 159
Leng S, 2004, Acta Pharmacol Sin, 25, 496
Wang SH, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 926
Han J, 2011, Med Sci Monit, 17, RA164
Peychev L., 2005, Pharmacia, 52, 118
Olmez E, 1992, Arzneimittelforschung, 42, 1095
Ko WH, 2000, Eur J Pharmacol, 399, 187, 10.1016/S0014-2999(00)00339-3 · DOI
Huang WM, 1992, Chin Med J, 105, 1014
Cheng F, 2012, Int J Cardiol
Xu MG, 2008, Cardiology, 112, 279
Huang CG, 1991, Comun Inform Pharm, 9, 10

Sorted by citations

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630
Berberis Vulgaris and Berberine: An Update Review
Imenshahidi, M., & Hosseinzadeh, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5693 · Cited by 375
Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Habtemariam, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104722 · Cited by 352
Transforming berberine into its intestine-absorbable form by the gut microbiota
Feng, R., Shou, J.-W., Zhao, Z.-X., He, C.-Y., Ma, C., Huang, M., Fu, J., Tan, X.-S., Li, X.-Y., Wen, B.-Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12155 · Cited by 307
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O. S., Djuric, D. M., Владиславович, Е. М., Fras, Z., Katsiki, N., Langlois, M. R., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 303
Self-citation

See all 173

Authors: Derosa, G., Maffioli, P., & Cicero, A. F.
Affiliations: University of Pavia (IT)
University of Bologna (IT)
ORCID: Derosa, Giuseppe
Maffioli, Pamela
Cicero, Arrigo FG
Venue: Expert Opinion on Biological Therapy
Publisher: Informa UK Limited
Published: 2012-07-11
Volume: 12
Issue: 8
Pages: 1113-1124
ISSN: 1471-2598 (ISSN-L)
1744-7682
DOI: 10.1517/14712598.2012.704014
OpenAlex: W2008978505
Cited by: 171
References: 91
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 10 · 2021: 9 · 2020: 17 · 2019: 8 · 2018: 16 · 2017: 10 · 2016: 21 · 2015: 19 · 2014: 16 · 2013: 8 · 2012: 1
FWCI: 1.63
Type: journal article
Language: en
Update notices: expression_of_concern (2018-05-16)
addendum (2018-05-11)
Open access: closed
Locations: Expert Opinion on Biological Therapy (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: berberine, type 2 diabetes, hypercholesterolemia, cardiovascular disease prevention, glycemic control, lipid profile, hypolipidemic effect, anti-diabetic effects, bioavailability, drug safety, natural alkaloids
MeSH terms: Animals, Anticholesteremic Agents, Berberine Alkaloids, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Humans, Hypercholesterolemia, Hypoglycemic Agents, Risk Factors, Biomarkers, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks